306 related articles for article (PubMed ID: 8889507)
1. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.
Orlow I; Iavarone A; Crider-Miller SJ; Bonilla F; Latres E; Lee MH; Gerald WL; Massagué J; Weissman BE; Cordón-Cardó C
Cancer Res; 1996 Mar; 56(6):1219-21. PubMed ID: 8640801
[TBL] [Abstract][Full Text] [Related]
3. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
Hatada I; Mukai T
Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
[TBL] [Abstract][Full Text] [Related]
4. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
[TBL] [Abstract][Full Text] [Related]
5. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.
Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T
Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay.
Reid LH; Crider-Miller SJ; West A; Lee MH; Massagué J; Weissman BE
Cancer Res; 1996 Mar; 56(6):1214-8. PubMed ID: 8640800
[TBL] [Abstract][Full Text] [Related]
7. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
[TBL] [Abstract][Full Text] [Related]
8. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
[TBL] [Abstract][Full Text] [Related]
12. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
[TBL] [Abstract][Full Text] [Related]
13. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors.
Hatada I; Inazawa J; Abe T; Nakayama M; Kaneko Y; Jinno Y; Niikawa N; Ohashi H; Fukushima Y; Iida K; Yutani C; Takahashi S; Chiba Y; Ohishi S; Mukai T
Hum Mol Genet; 1996 Jun; 5(6):783-8. PubMed ID: 8776593
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
16. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
[TBL] [Abstract][Full Text] [Related]
18. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain.
Cooper PR; Smilinich NJ; Day CD; Nowak NJ; Reid LH; Pearsall RS; Reece M; Prawitt D; Landers J; Housman DE; Winterpacht A; Zabel BU; Pelletier J; Weissman BE; Shows TB; Higgins MJ
Genomics; 1998 Apr; 49(1):38-51. PubMed ID: 9570947
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
Chung WY; Yuan L; Feng L; Hensle T; Tycko B
Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]